MPS Pharmaa Share Price

MPS Pharmaa Limited (Formerly known Advik Laboratories Limited) was incorporated in September, 1994. The Company was promoted in by the Jains along with a group of dedicated professionals. Presently, it is engaged in the manufacture and sale of pharmaceutical products in India. It offers ethical, generic, and over the counter drugs in various formulations. The companys generic product portfolio comprises antibacterial antiallergics antifungals analgesic, antipyretic, and antiinflammatory antihypertensives anthelminthics antimalarials corticosteroids erectile dysfunction gastrointestinal agents sedatives and other miscellaneous products. The company commenced commercial production in 1997. In his leadership, the company has witnessed a fast growth rate, without compromise to quality.During the year 20032004, the company established their brand, Zin Ten (an anti allergic tablets) in the oversea market. During the year 20042005, the company launched the new marketing set up and necessary approvals were taken for the new range of product like Majispa, Robial, ChewfeC, Stibomin, Wibatol, WibatolO, Twosum, and Arfagel. During the year 20072008, the company compliance of current guidelines requires good amount of funds for modernization of its plant as per standards of WHOGMP level.In 202122, the Company became an Associate Company of Vikas Lifecare Limited as it had acquired 22.04% of the shareholding of the Company. As a result, on 20062022, Vikas Lifecare Limited divested 04.53% shareholding of the Company thereby its aggregate shareholding into the Company decreased to 17.51% and hence, the Company ceased to be an Associate of Vikas Lifecare Limited.

As of 20 Jan 2026, MPS Pharmaa share price is ₹1.7. The stock opened at ₹1.8 and had closed at ₹1.8 the previous day. During today’s trading session, MPS Pharmaa share price moved between ₹1.68 and ₹1.76, with an average price for the day of ₹1.72. Over the last 52 weeks, the stock has recorded a low of ₹1.68 and a high of ₹4.29. In terms of performance, MPS Pharmaa share price has declined by 38.2% over the past six months and has declined by 59.91% over the last year.